Europe IV Hydration Therapy Market to Surpass US$ 427.0 Mn by 2030 - Coherent Market Insights

Europe IV Hydration Therapy Market, by Service Type (Immune Booster, Hangover Cure, Energy Booster, Skin Care, and Others), by Component Type (Medicated and Non-Medicated), by Activity (Emergency Healthcare and Emergency Healthcare), and by Country (Germany, U.K., France, Italy, Spain, Austria, Switzerland, The Netherlands, Belgium, and Rest of Europe) is estimated to be valued at US$ 244.1 Million in 2022 and is expected to exhibit a CAGR of 7.2% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

Increased funding from government for developing technological advanced IV therapies is expected to drive the market growth over the forecast period. For instance, in May 2019, Tada Medical AB, a Sweden-based medical technology start-up specializing in IV therapy, received €3m (~US$ 3.3 Mn) funding from the European Innovation Council for its two-year Swirl SAFE-infusion project which focuses on developing technological advanced IV therapies incorporating remote monitoring in order to improve IV delivery of medicine, fluid, etc. Swirl SAFE-infusion project was initiated in April 2021 and is expected to be completed by March 2023.

Europe IV Hydration Therapy Market – Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors. The private healthcare sector is one such sectors that has been majorly impacted by the pandemic

However, the COVID-19 pandemic had a positive impact on the Europe IV hydration therapy market, owing to the increasing research by research institutes on the potential benefits and use of IV therapy in COVID-19 patients. For instance, the article published in PubMed, a database of references and abstract in life science, on August 1, 2020, stated the use of IV vitamin C for patients with COVID-19. The researchers reviewed the feasibility of using vitamin C IV in a series of COVID-19 patients. According to the results there was a significant decrease in inflammatory markers, including ferritin and D-dimer, and a trend to decreasing FiO2 requirements, after vitamin C administration. Thus, the use of IV vitamin C in patients with moderate to severe COVID-19 disease was found to be feasible.

Browse 34 Market Data Tables and 88 Figures spread through 200 Pages and in-depth TOC on “Europe IV Hydration Therapy Market”-  Forecast to 2030, Europe IV Hydration Therapy Market, by Service Type (Immune Booster, Hangover Cure, Energy Booster, Skin Care, and Others), by Component Type (Medicated and Non-Medicated), by Activity (Emergency Healthcare and Emergency Healthcare), and by Country (Germany, U.K., France, Italy, Spain, Austria, Switzerland, The Netherlands, Belgium, and Rest of Europe)

To know the latest trends and insights prevalent in the Europe IV Hydration Therapy Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/europe-iv-hydration-therapy-market-5021

Moreover, market players in Europe are focused on raising capital for their IV infusion therapy devices, which is expected to drive the market growth over the forecast period. For instance, in August 2020, Monidor Oy (Ltd), a Finland-based health technology start-up, raised a capital of €1 million (~US$ 1.2 m) in order to enhance its infusion therapies business.

Key Takeaways of the Europe IV Hydration Therapy Market:

• The Europe IV hydration therapy market is expected to exhibit a CAGR of 7.2% during the forecast period due to the increasing foodborne outbreaks. For instance, according to data published by the European Food Safety Authority in December 2019, it was estimated that around 5,146 foodborne outbreaks occurred in the EU which affected nearly 48,365 people in 2018. Also, the same source stated that one in every three foodborne outbreaks were caused by Salmonella in the European Union (EU) in 2018.
• Among service type segments, the immune booster segment is estimated to hold a dominant position in the Europe IV hydration therapy market over the forecast period, owing to the presence of key market players offering mobile immune booster IV hydration therapy services in Europe. For instance, Drip Hydration, a mobile IV therapy company serving all over Europe, offers in-home Immune Boost IV hydration therapy service to deliver Glutathione Push, B-Complex Vitamins, Vitamin B12, Vitamin C, and hydration to the body, in order to allow quick illness recovery and protect against viral and bacterial infection.
• On the basis of activity, the emergency healthcare segment is estimated to account for the largest market share in the Europe IV hydration therapy market over the forecast period, as key players are involved in offering a variety of mobile IV hydration therapy services which allows patients to treat dehydration emergencies in the comfort of their own home. For instance, The IV Doc Inc., a global provider of in-home IV therapy, offers food poisoning IV hydration therapy services in Chester, Ibiza, Liverpool, London, and Manchester for treatment of food poisoning.
• Major players operating in the Europe IV hydration therapy market include REVITA, Ivtherapygreece, IV Boost UK, Harpal Clinic Limited, IV Drips London, VITAMIN INJECTIONS LONDON, Cryojuvenate UK Ltd., Italy Health Retreats, Séchoir, ELIXIR, Swiss Medical Centre, Drip Hydration, REVIV, VITANOVAS, and The IV Doc Inc.